相关实验视频

Updated: Jun 17, 2025

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.7K

对于膀癌的协同性静脉灌注:CRISPR-Cas13a和班达的联合治疗

Mingkang Liang1,2, Yongqiang Wang3, Lisha Liu1

  • 1Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen, Guangdong, 518000, China.

Journal of experimental & clinical cancer research : CR
|August 11, 2024
PubMed
概括

这项研究引入了用于膀癌的新型CRISPR-Cas13a纳米平台,有效减少PDL1表达并增强抗瘤免疫力. 这种创新方法对静脉癌症治疗具有前途.

关键词:
膀癌是一种癌症.这就是CRISPR-Cas13a.弗卢本达 (Flubendazole) 是一种药物.化基多的含有的基多.编程死亡联体1编程死亡联体1通过膜的化物.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K